Articles related to KIDNEY DISEASE

The 2026 KDIGO anemia in CKD guideline replaces two long-standing iron deficiency classifications, endorses proactive high-dose IV iron in maintenance hemodialysis, and provides first-ever positioning guidance on HIF-PHIs, 14 years after the previous version.

Infection-related complications remain the most significant cause for morbidity and technique failure in infants, children and adolescents who receive maintenance peritoneal dialysis (PD).

These medications can reduce blood flow through the kidneys, which can contribute to kidney damage or failure. Patients with heart failure, liver disease, or existing kidney problems are at a higher risk.

“This guideline is a tour de force, not just a technical manual. It’s a roadmap for precision, prevention, and equity in hypertension care.” – Ragavendra Baliga, MBBS

Similar efficacy was observed in pediatric patients aged 12 years and older – demonstrating consistent treatment benefit across age groups in the pivotal trial.

Nationwide analysis of more than 75,000 patients reveals consistent CKD risk elevation across all age groups and genders, with strongest associations in patients requiring frequent clinical interventions.